NEW YORK (GenomeWeb News) - John Stuelpnagel, Illumina’s senior VP, COO and GM for arrays, will shift to a part-time status in April and will give up his seat on the board of directors, although he will continue to work as an Illumina fellow, the firm said this week.
 
Illumina also said Senior VP and GM of Sequencing John West will resign his position as of Feb. 1, and current senior VP and CFO Christian Henry will become acting manager of sequencing.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.